Late-phase pulse-inversion sonography using the contrast agent levovist: Differentiation between benign and malignant focal lesions of the liver

American Journal of Roentgenology

Volumn 179, Issue 5, 2002, Pages 1273-1279

  Von Herbay, Alexandra ^a   Vogt, Christoph ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SHU 508;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LIVER SCINTISCANNING; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0036839086     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.179.5.1791273     Document Type: Article

References (34)

1. Forsberg F. Goldberg BB, Liu JB, Merton DA, Rawool NM, Shi WT. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology 1999;210:125-132
2. Schlief R. Galactose-based echo-enhancing agents. In: Goldberg BB. ed. Ultrasound contrast agents. London: Dunitz, 1997:75-82
3. Harvey CJ, Blomley MJ, Eckersley RJ, Heckemann RA, Butler-Barnes J, Cosgrove DO. Pulseinversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 2000;355:807-808
4. Bauer A, Hauff P, Lazenby J, et al. Wideband harmonic imaging: a novel contrast ultrasound imaging technique. Eur Radiol 1999;9[suppl 3]:S364-S367
5. Albrecht T, Hoffmann CW, Schettler S, et al. B-mode enhancement at phase-inversion US with airbased microbubble contrast agent: initial experience in humans. Radiology 2000;216:273-278
6. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002;222:95-102
7. Shi WT, Forsberg F. Ultrasonic characterization of the nonlinear properties of contrast microbubbles. Ultrasound Med Biol 2000;26:93-104
8. Burns PN, Hope Simpson D, Averkiou MA. Nonlinear imaging. Ultrasound Med Biol 2000;26[suppl 1]:S19-S22
9. Albrecht T, Hoffmann CW, Schettler S, Overberg A, Ilg M, Wolf KJ. Improved detection of liver metastases with phase inversion imaging during the liver-specific phase of the ultrasound contrast agent Levovist. Eur Radiol 1999;9[suppl 3]:S388
10. Albrecht T, Barr R, Blomley M, et al. Seeking consensus: contrast ultrasound in radiology. Invest Radiol 2002;37:205-214
11. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects, revised. Edinburgh: World Medical Association, 2000
12. Campani R, Calliada F. Bottinelli O, et al. Contrast media in ultrasonography: hepatic focal lesions. Radiol Med 1998;95[suppl 1]:47-52
13. Goldberg BB, Liu JB. Burns PN, Merton DA, Forsberg F. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med 1993;12:463-470
14. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for color Doppler US: effect on breast masses. Radiology 1996;198:679-686
15. Maruyama H, Matsutani S, Sato G, et al. Enhanced color flow images in small hepatocellular carcinoma. Abdom Imaging 2000;25:164-171
16. Strobel D, Krodel U, Martus P, Hahn EG, Becker D. Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors. J Clin Ultrasound 2000;28:1-13
17. Cohen A. Comparison of correlated correlations. Stat Med 1989;8:1485-1495
18. Brenner H, Kliebsch U. Dependence of weighted kappa coefficients on the number of categories. Epidemiology 1996;7:199-202
19. Swensson RG, King JL, Gur D. A constrained formulation for the receiver operating characteristic (ROC) curve based on probability summation. Med Phys 2001;28:1597-1609
20. Dorfman DD, Berbaum KS, Metz CE. Receiver operating characteristics rating analysis: generalization of the population of readers and patients with the jackknife method. Invest Radiol 1992;27:723-731
21. Rogers JV, Mack LA, Freeny PC, Johnson ML, Sones PJ. Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy. AJR 1981;137:983-990
22. Rubin RA, Lichtenstein GR. Hepatic scintigraphy in the evaluation of solitary solid liver masses. J Nucl Med 1993;34:697-705
23. Piers DA, Houthoff HJ, Krom RA, Schuur KH, Sikkens H, Weits H, Welts J. Hot spot liver scan in focal nodular hyperplasia. AJR 1980;135:1289-1292
24. Welch TJ, Sheedy PF 2nd, Johnson CM, et al. Focal nodular hyperplasia. and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy. Radiology 1985;156:593-595
25. 99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. J Nucl Med 1989;30:1278-1280
26. Hundt W, Petsch R, Helmberger T, Reiser M. Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis. Eur Radiol 2000;10:409-416
27. Mintorovitch J, Shamsi K. Eovist injection and Resovist injection: two new liver-specific contrast agents for MRI. Oncology 2000:14[suppl 3]:37-40
28. Orsatti G, Theise ND, Thung SN, Paronetto F. DNA image cytometric analysis of macroregenerative nodules (adenomatous hyperplasia) of the liver: evidence in support of their preneoplastic nature. Hepatology 1993;17:621-627
29. Tung GA. Cronan JJ. Percutaneous needle biopsy of hepatic cavernous hemangioma. J Clin Gastroenterol 1993;16:117-122
30. Bottinelli O, Callida F, Campani R, et al. Specific features of hepatic lesions on pulse inversion and intermittent imaging after ultrasound contrast agent injection. (abstr) Ultrasound Med Biol 2000:26[suppl 2]:A138
31. 99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation. J Nucl Med 1988;29:1916-1920
32. Dalla Palma L, Bertolotto M, Quaia E, Locatelli M. Detection of liver metastases with pulse inversion harmonic imaging: preliminary results. Eur Radiol 1999;9[suppl 3]:S382-S387
33. Albrecht T, Hoffmann CW, Schmitz SA, et al. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases, AJR 2001;176:1191-1198
34. Kratzer W, Kachele V, Merkle E, et al. Contrast enhanced power Doppler sonography: comparison of various administration forms of the ultrasound contrast agent Levovist [in German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2000;172:443-148